Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

Por Feliu, J, Barriuso, J
Publicado em 2011

Stimulatory effect of the intestinal peptide PHI on glycogenolysis and gluconeogenesis in isolated rat hepatocytes.

Por Felíu, J E, Marco, J
Publicado em 1983

Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma

Por Lamarca, A, Feliu, J, Barriuso, J
Publicado em 2012

Short-term regulation of glycolysis by vasoactive intestinal peptide in epithelial cells isolated from rat small intestine.

Por Rossi, I, Monge, L, Feliu, J E
Publicado em 1989

Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes.

Por Feliú, J E, Hue, L, Hers, H G
Publicado em 1976

Nucleotide sequence of the Schizosaccharomyces pombe 25S ribosomal RNA and its phylogenetic implications.

Por Lapeyre, B, Michot, B, Feliu, J, Bachellerie, J P
Publicado em 1993

Study of multiple fibrillarin mRNAs reveals that 3' end formation in Schizosaccharomyces pombe is sensitive to cold shock.

Por Girard, J P, Feliu, J, Caizergues-Ferrer, M, Lapeyre, B
Publicado em 1993

Differences in the Vulnerability of Waterbird Species to Botulism Outbreaks in Mediterranean Wetlands: an Assessment of Ecological and Physiological Factors

Por Anza, I., Vidal, D., Feliu, J., Crespo, E., Mateo, R.
Publicado no Appl Environ Microbiol (2016)

Permeabilization of animal cells for kinetic studies of intracellular enzymes: in situ behavior of the glycolytic enzymes of erythrocytes.

Por Aragón, J J, Felíu, J E, Frenkel, R A, Sols, A
Publicado em 1980

Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain

Por Sanchez-Gutierrez, J, Benlloch, T, Leal, M, Samper, B, Garcia-Ripoll, I, Feliu, J
Publicado em 2002

Transport in isolated rat hepatocytes of the phospho-oligosaccharide that mimics insulin action. Effects of adrenalectomy and glucocorticoid treatment.

Por Alvarez, J F, Sánchez-Arias, J A, Guadaño, A, Estévez, F, Varela, I, Felíu, J E, Mato, J M
Publicado em 1991

SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)

Por Vera, R., Dotor, E., Feliu, J., González, E., Laquente, B., Macarulla, T., Martínez, E., Maurel, J., Salgado, M., Manzano, J. L.
Publicado no Clin Transl Oncol (2016)

Clinical guideline SEOM: hepatocellular carcinoma

Por Sastre, J., Díaz-Beveridge, R., García-Foncillas, J., Guardeño, R., López, C., Pazo, R., Rodriguez-Salas, N., Salgado, M., Salud, A., Feliu, J.
Publicado no Clin Transl Oncol (2015)

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

Por Sastre, J., Argilés, G., Benavides, M., Feliú, J., García-Alfonso, P., García-Carbonero, R., Grávalos, C., Guillén-Ponce, C., Martínez-Villacampa, M., Pericay, C.
Publicado em 2014

Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

Por Feliu, J, Artal, A, González Barón, M, Berrocal, A, Chacón, I, García de Paredes, M L, Espinosa, E, Ordóñez, A, Zamora, P, Montero, J M
Publicado em 1992

Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer

Por Feliu, J, Vicent, J M, García-Girón, C, Constela, M, Fonseca, E, Aparicio, J, Lomas, M, Antón-Aparicio, L, Dorta, F J, Gonzalez-Baron, M
Publicado em 2004

Phase 1 and Extension Study of Clofarabine plus Cyclophosphamide in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Por Faderl, S, Balakrishnan, K, Thomas, DA, Ravandi, F, Borthakur, G, Burger, J, Ferrajoli, A, Cortes, J, O’Brien, S, Kadia, T, Feliu, J, Plunkett, W, Gandhi, V, Kantarjian, HM
Publicado em 2013

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

Por Feliu, J, Castañón, C, Salud, A, Mel, J R, Escudero, P, Pelegrín, A, López-Gómez, L, Ruiz, M, González, E, Juárez, F, Lizón, J, Castro, J, González-Barón, M
Publicado em 2005

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

Por Feliu, J, Salud, A, Escudero, P, Lopez-Gómez, L, Bolaños, M, Galán, A, Vicent, J-M, Yubero, A, Losa, F, De Castro, J, de Mon, M Á, Casado, E, González-Barón, M
Publicado em 2006

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

Por Feliu, J, Safont, M J, Salud, A, Losa, F, García-Girón, C, Bosch, C, Escudero, P, López, R, Madroñal, C, Bolaños, M, Gil, M, Llombart, A, Castro-Carpeño, J, González-Barón, M
Publicado em 2010